Bistos Co Ltd
Bistos Co Ltd has a market price of 877 KRW per share, with a market capitalization of 19.64 billion KRW. The company's price-to-book ratio is 1.1, and its price-to-tangible-book ratio is also 1.1, indicating a valuation in line with tangible asset value. The enterprise value to EBITDA ratio is negative at -18.14, reflecting the company's current operating losses. The enterprise value to revenue ratio is 1.16, suggesting a modest revenue-based valuation. The company's profitability metrics are weak, with a return on equity of -3.9% and a return on assets of -3.38%. These figures are below the industry median for Advanced Medical Equipment & Technology, which typically shows positive returns. The company's operating income is negative at -1.096 billion KRW, and its net income is also negative at -699.12 million KRW, indicating a lack of profitability. Bistos Co Ltd's revenue is concentrated in disclosed segments, though specific geographic breakdowns are not provided in the input data. The company's exposure to geographic markets is not quantified, but its operations are based in Korea, which may limit diversification. The company's capital structure is relatively conservative, with a debt-to-equity ratio of 0.01, and a current ratio of 5.34, indicating strong short-term liquidity. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the input data. Historical revenue data shows a revenue of 17.1 billion KRW, but without prior periods, it is difficult to assess year-over-year performance. The company's operating cash flow is negative at -2.168 billion KRW, and its free cash flow is also negative at -427.27 million KRW, indicating cash flow challenges. The company's risk profile includes a medium liquidity risk, with a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no immediate pressure for share issuance. The company's capital expenditures are negative at -188.06 million KRW, suggesting a reduction in investment in physical assets. Recent events and filings are not detailed in the input data, but the company's financial performance and cash flow position suggest a need for operational improvements. The company's negative operating and net income, combined with negative cash flows, indicate a need for strategic adjustments to achieve profitability.
Business. Bistos Co Ltd is a Korea-based company engaged in the researching, developing, and manufacturing of medical equipment, including fetal monitors, patient monitors, infant incubators, and phototherapy devices.
Classification. Bistos Co Ltd is classified under the Healthcare sector, specifically in the Advanced Medical Equipment & Technology industry, with a confidence level of 0.92.
- Bistos Co Ltd is currently unprofitable, with negative operating and net income.
- The company's valuation is modest, with a price-to-book ratio of 1.1 and a negative EV/EBITDA ratio.
- Liquidity is strong, with a current ratio of 5.34, but cash flow is negative.
- The company's debt-to-equity ratio is low at 0.01, indicating a conservative capital structure.
- Growth prospects are unclear due to the lack of forward-looking revenue projections.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.